|1||The future of precision nutrition, now! Takezo offers personalized & ready-made premium supplements.|
|2||Launch w/ Custom EQUIP Immunity/multi vitamin shot, Focus drink mix, GeneLytics DNA trait reports.|
|3||Deep leadership bench is a well-oiled machine, primed to execute and scale up our business model.|
|4||U.S. TAM of $67.1B, annual growth of 7.86% (CAGR). Within a global market tracking to $130B (5 yr).|
|5||No-Pills! Non-pill formats now account for 52% of supplement sales across all channels.|
|6||Takezo 5-year proforma revenue > $40m at 70% AGM and attracting & retaining 58K loyal subscribers.|
|7||Leveraging ML & AI to create personalized products that can be updated, & a dynamic data ecosystem.|
|8||Takezo technology platform will offer multiple potential revenue streams, both B2C and B2B.|
Takezō is dedicated to your comprehensive wellness and personal performance. Optimum health & wellness requires proper nutrition and lifestyle. Every person has unique goals & dietary preferences, as well as unique genetic & biologic markers. Did you know that even identical twins can respond differently to the same food?
We offer personalized supplements that are precision fit for you, & ready-made premium nutritional products, designed to help you function at your best.
Our personalized EQUIP™ comes in 3 delicious flavors of ready to eat fruit puree and potential for 87 billion possible ingredient combinations, and we are launching with customizable Equip FIT daily multi vitamin + Immunity boost + Energy.
To enable consumers to understand where their genetic strengths and potential issues reside, we offer GeneLytics. GeneLytics is a series of 6 DNA Trait reports including Nutrigenomics (Diet & Metabolism + Vitamin & Mineral Traits), Fitness and Exercise, Personality Profile, Skin Profile, as well as Allergy & Sensitivity traits. A simple upload of a 23&Me or Ancestry.com, and we generate the reports. These reports can also help inform us of what customizations we should make to your EQUIP products. Click here to see one of our co-founders GeneLytics Nutritional Traits Report.
Additionally, Takezo offers 4 tasty, functional drink mix powders designed to support you on your daily journey. ENERGY™, FOCUS™, REST™, & REVIVE™ are perfect companions to your daily hydration routine and are loaded with hand-picked, trademarked ingredients, backed by research. Takezo believes in transparency so we don't use any "proprietary blends" and we chose non-gmo & botanical ingredients that are Keto friendly, with performance you can feel.
To help you achieve your mission, we also provide personal performance technology and tools, along with the support of a like-minded Tribe of fellow humans .
Takezo is: “For you–By Us”
Our Mission: To be the most effective, inspirational, and trusted personal performance brand in the world.
Why did Takezo start?
Through the shared experiences of our founders, we identified significant opportunities in the personal performance & wellness category, including personalized (ready to eat) daily supplements, premium functional drink mixes, genomic and metabolic reporting, and other personal performance technology.
Our founders are athletes and executives, always seeking an effective, safe, and legal personal performance edge. They have had their DNA ‘run’ several times and participated in studies such as Predict 2 by Zoe Global Limited. The key consensus is that we are unique, and in fact identical twins react completely different to the same foods taken at the same time.
As individuals, we also looked for solutions to leverage this information, previously not available nor affordable, to help us achieve our personal objectives, in an integrated fashion. What we found were some amazing tools but limited options allowing us to "connect the dots" from these multiple information sources into a manageable personal plan.
Digging deeper into the industry, we recognized over $600 million that had recently been invested into companies providing at-home DNA and Microbiome testing. MIT Technology (Link to article) predicts that by 2022, 100 million people will have their DNA data. Additionally, advancements in wearables, trackers and at home testing technology has encouraged the release of over 165k technology apps designed to leverage the personal performance data and provide a variety of targeted services. Absent in the development ecosystem was an initiative to integrate the data technology, nutrition science and advanced manufacturing to generate aligned nutrition products in support of an individual's personal objectives. The founders of Takezo determined to address this gap, and by doing so, position the company in a global personalized nutrition & wellness market, currently projected to reach $130 billion over the next five years.
The Takezo team has identified a large segment of the US total supplement and functional markets, zeroing in on a target population representing $67.1b market with an average CAGR of 7.86%. Supporting our market identification is information from New Hope Network indicating that 77% of the US adult population take dietary supplements and, poignantly, 68% of the unemployed continue to take supplements.
Competitive analysis revealed an opportunity to achieve a defensible leadership position in the personalized (custom) and functional supplement market. And, in fact, there is little in the way of competitive activity in the broader personalized nutrition market.
One of our founders (Reid) used one of the recently developed technology service offerings to look at his specific nutrigenetics (how genes influence the utilization of nutrients and bioactive compounds), based on his 23&Me™ DNA results , and this is some of what he discovered using the Takezo GeneLytics engine (image below):
Armed with this information, Reid sought out supplements that would help him fix his specific supplement gaps. His search for solutions to help him personalize his supplement regimen didn't yield many results outside of those requiring too many pills to swallow. In addition to learning what gaps needed to be filled, Reid also learned that supplementing with Vitamin E could likely be harmful to his overall health. Personalized nutrition was going to mean developing solutions for what consumers need and for what they don't need.
All this was happening while Takezo addressed another industry problem; we saw an opportunity for functional beverages as a pre-mixed foundation for future personalization options such as add caffeine/CBD or remove Ashwagandha. We noted that most existing functional drinks/drink mixes were loaded with sugar and contained "Proprietary Blends" (hidden ingredients), neither of which aligned with our Vision of a world void of metabolic syndrome & preventable chronic disease. We developed three daily functions that adults across multiple segments face daily: ENERGY™, FOCUS™, REST™. The Team also developed REVIVE™ to help reduce the negative effects of periodic alcohol consumption and to support a healthy immune system. Takezo iterated each function at least 7 times to get the right key ingredients and dosage combinations to ensure the desired effect & flavor without added sugars and with full ingredient transparency. These four functions can be deployed as both standalone powdered drink products and as added modules within the personalization system.
While the powders were being developed & being primed for market launch, Takezo was exploring how to bring hyper-personalization to the masses. We sought to build a system through which a consumer could easily configure ready to eat or ready to mix products based on their personal objectives, values, while also addressing nutritional gaps they may think or know they have.
During these two large projects The Takezo Leadership team was built to include our Board of Directors, advisors and industry partners. Additionally, as much as technology is central to the Takezo consumer experience, it is also critical in managing a dynamic business. Recognizing this, the team identified comprehensive software solutions and has begun the incremental implementation of scalable management practices on this foundation.
All of this brings us to where we are now...
Takezo is now set to launch products to the general market. We expect to proceed in four phases. Phase 1 will offer our GeneLytics™ reports, limited quantity / configurable EQUIP FIT™, and Takezo FOCUS™. Subsequent phases expected in 2020 include launch of our additional Functions (ENERGY™, REST™, & REVIVE™) and the ability to personalize them, expanded EQUIP FIT™ personalization options and a consumer facing app with wearable integrations. Takezo seeks to deliver all this while building an online and physical tribe of like-minded people supported by a tribe of mentors. The tribe platform content will be determined in collaboration with our consumers, so as to be most relevant, and of course we will attempt to personalize it for you.
From a future development point of view, we have identified opportunities to customize the existing functional drink mixes as well as a customizable, nutrient dense meal replacement ready to mix powder. We will also be paying attention to the customization our consumers make, taking note of any trends that may guide the launch of standardized product based on those formulations. This will allow Takezo to expand market distribution and awareness while profiting from the lower costs of goods sold afforded by standardized production.
Our approach to this vast market opportunity leverages artificial intelligence, machine learning, and advanced/robotic food manufacturing systems. These solutions while seeming complex, come naturally to many on the Takezo team. With these complexities, also comes a barrier to entry by others interested in competing directly with Takezo on all fronts.
Our technology solutions focus on easing the friction for the consumer, while minimizing the operational complexities for Takezo. An example is our bot that we trained for the convenience of the consumer. This bot guides a consumer through a 3-minute Q&A that helps us identify some potential nutritional gaps, leading to a "first-pass" at a personalized product. The bot presents a choice allowing the consumer to purchase the configured product or to continue on the interview, resulting in a more customized product. For our consumer, more customized = a better match with their needs and a more fulfilling experience. For Takezo this not only results in better consumer satisfaction but also in a much closer and longer-lasting relationship with that consumer by building in higher switching costs. (See video of experience here:)
We have identified a large target population of consumers. Our core consumer likes to plant flags, whether it is training to finish that charity bike ride/run/walk, lower their handicap, excel at their e-sport game(s), achieve that next level in training, or even setting a goal to win the Spartan Race Global Championships, Takezo is on that journey with each consumer.
Our marketing strategy is well traveled and proven by the most successful direct brands. We plan on attracting and retaining our consumers with a modern 360-degree marketing plan, that will be managed in house and executed by partners in performance marketing. In addition to paid media, our approach will include editorial, consumer submitted & original content, event participation / sampling / activation (Spartan Race partnerships), and earned media/PR. Takezō has engaged some of the leading performance marketing resources to help up us win the hearts, minds, and the share of stomach of our consumers.
We are deploying an Omnichannel Revenue Generation model, that will enable direct to consumer and retail options for the convenience of our consumers. We strive to normalize pricing across our channels, as well as provide value & products exclusive to each revenue channel. Takezo has entered into an agreement with the 3rd largest (globally) sports nutrition e-tailor and will onboard with this customer 6 weeks after funding.
An important goal of the Takezo Founders has been to build an investment-ready company. We have made significant traction since our inception resulting in a portfolio of market-ready products including GeneLytics™ Trait Reports, Takezo FOCUS™ (32 serving stand up pouch) and EQUIP. Takezo is positioned to be in-market delivering on investment value within a few weeks of successful funding.
We have built & continue to build this company to eventually be bundled and sold. We expect to have a few more funding rounds after this one is completed.
Come join us and become a part of a team that has a winning combination:
Takezo has financial statements ending December 31 2019. Our cash in hand is $216, as of April 2020. Over the three months prior, revenues averaged $0/month, cost of goods sold has averaged $0/month, and operational expenses have averaged $2,510/month.
Management’s Discussion and Analysis of Financial Condition and Results of Operations
You should read the following discussion and analysis of our financial condition and results of operations together with our financial statements and the related notes and other financial information included elsewhere in this offering. Some of the information contained in this discussion and analysis, including information regarding the strategy and plans for our business, includes forward-looking statements that involve risks and uncertainties. You should review the "Risk Factors" section for a discussion of important factors that could cause actual results to differ materially from the results described in or implied by the forward-looking statements contained in the following discussion and analysis.
Takezō is dedicated to your comprehensive wellness and personal performance. We offer personalized & ready-made premium supplements, designed to help you function at your best. To help you achieve your mission, we provide personal performance technology, and the support of a like minded Tribe.
Our mantra is “For you – By Us”
Equip FIT has roughly 87 billion potential identified ingredient combinations, and hope to grow that to a few trillion. Our RTM includes Focus, Energy, Rest, & Revive.
In five years, we want to be the #1 provider of personalized nutritional solutions in the world, although this cannot be guaranteed.
Given the Company’s limited operating history, the Company cannot reliably estimate how much revenue it will receive in the future, if any.
Takezo LLC was organized in the State of Delaware in May 2018. It was the intent of management from inception to attract recognized subject matter leaders for each of the business areas in which we seek to establish unique competitive advantage. Additionally it has been a Takezo guiding principle to build out consumer and market-ready solutions prior to operational launch and thus be in a position to realize revenue quickly, post funding. Key leaders of Takezo have invested considerable knowledge capital to self-fund Takezo to prepare for a rapid path to revenue for investors (we hope). To this end, we believe Takezo is poised for that rapid launch. The Takezo Focus product is purchase-order ready with approved packaging. Equip FIT has final technology & process configuration steps remaining with our co-manufacturer, the timeline of which has been impacted by COVID. Dynamics in the economy may allow Takezo initiate an introduction of minimally configurable Equip coincident with this offering
Since then, we have:
Historical Results of Operations
Our company was organized in May 2018 and has limited operations upon which prospective investors may base an evaluation of its performance.
Liquidity & Capital Resources
After the conclusion of this Offering, should we hit our minimum funding target, our projected runway is 4 months before we need to raise further capital.
We plan to use the proceeds as set forth in this Form C under "Use of Funds". We don’t have any other sources of capital in the immediate future.
We will likely require additional financing in excess of the proceeds from the Offering in order to perform operations over the lifetime of the Company. We plan to raise capital in 2 months. Except as otherwise described in this Form C, we do not have additional sources of capital other than the proceeds from the offering. Because of the complexities and uncertainties in establishing a new business strategy, it is not possible to adequately project whether the proceeds of this offering will be sufficient to enable us to implement our strategy. This complexity and uncertainty will be increased if less than the maximum amount of securities offered in this offering is sold. The Company intends to raise additional capital in the future from investors. Although capital may be available for early-stage companies, there is no guarantee that the Company will receive any investments from investors.
Runway & Short/Mid Term Expenses
Takezo LLC cash in hand is $216, as of April 2020. Over the last three months, revenues have averaged $0/month, cost of goods sold has averaged $0/month, and operational expenses have averaged $2,510/month, for an average burn rate of $2,510 per month. Our intent is to be profitable in 18 months. The founding team can infuse capital to cover short-term operations.
No material changes or trends in finances or operations have occurred since the date of the financials provided.
Based on the current financial forecast, we expect revenues to approach $185000 on roughly $300000 of expenses by the 3 month mark and total $900000 on $1 million of expenses 6 months out. This forecast assumes we achieve our mid-tier funding goal of $350k. Projections cannot be guaranteed.
$50k minimum raise will enable the maturation of a brand development marketing and advertising program, sales launch of our DNA-based health and nutrition reports, launch of Takezo Equip, and pre-orders of Takezo Focus. We forecast that this level of funding would help us achieve revenue at an annualized rate of $17k/month.
To-date, Takezo LLC has been self-funded. Once full operations are funded, Management plans to secure an operating line of credit to support cash availability as the business develops stronger operating cash flow. Our current 5-yr. business plan includes an operating line utilization of no more than 60% of $100000 availability.
Takezo LLC may never receive a future equity financing or elect to convert the Securities upon such future financing. In addition, the Company may never undergo a liquidity event such as a sale of the Company or an IPO. If neither the conversion of the Securities nor a liquidity event occurs, the Purchasers could be left holding the Securities in perpetuity. The Securities have numerous transfer restrictions and will likely be highly illiquid, with no secondary market on which to sell them. The Securities are not equity interests, have no ownership rights, have no rights to the Company’s assets or profits and have no voting rights or ability to direct the Company or its actions.
We are a Start-up company without prior revenues or sales.
Our business model, including sales and growth forecasts are unproven. While the model assumptions are informed by the considerable business experience of our management team and industry advisors, actual results will likely be different from those predicted by the model. Our financial results will differ from those forecasted and any valuation of Takezo LLC at this stage is difficult to assess.
Small management team.
Supply chain risks.
Takezo depends on a network of manufacturing/co-packer and fulfillment organizations to execute our business. The inability of any of these partner organizations to follow through on their commitment would require us to replace them with another partner. As a nutrition business, we carry certain food safety risks. We rely on the practices and certifications maintained by our supply chain partners to mitigate these safety risks.
Use of proceeds in this offering.
We are a food company.
As a food and supplement company we face certain risks related to both food safety and regulatory practices throughout our supply chain. We mitigate these risks to the business through management vigilance and peerless legal and risk management advisor firms. Importantly, we seek to protect our consumers by partnering with recognized, certified and equally minded supply chain partner firms. Additionally, as a food company we face unforeseen risk associated with unknown and unpredictable use of product by the consumer.
These are not all the risks.
We have highlighted here what we as the management team see as the main risks related to this offering. This is not a comprehensive list of all risks. For more risks associated with this offering, see the Offering Document and see the Wefunder FAQ page at https://help.wefunder.com/
Kim Terry, Patrick Connors, Bryan Emmerson and Karen Vaughn are part-time officers. As such, it is likely that the company will not make the same progress as it would if that were not the case.
Already have a Wefunder account? Login
Don't have a Wefunder account? Signup